Clinical Trials

BARRETT'S ESOPHAGUS

• Please check back soon
  

CROHN'S DISEASE

• A Pilot Study to Determine the Safety of an Oral Dose of Green Tea Extract and Provide Preliminary Evidence to Support Its Efficacy In Crohn's Disease

Principal Investigator: Gerald Dryden, M.D.  (502) 852-0156
Research Coordinator: Karen Beatty (502) 813-6564

• A randomized, double-blind, parallel-group, placebo controlled,induction trial to assess the clinical efficacy and safety of NNC0142-0000-0002 in subjects with moderately to severely active Crohn’s disease

Principal Investigator:  Gerald Dryden, M.D.  502-852-0156
Research Coordinator:  Susie Mann, L.P.N. 502-852-1919

DIVERTICULITIS

• Phase III clinical study on the efficacy and tolerability of mesalazine granules vs. placebo for the prevention of recurrence of diverticulitis

Principal Investigator:  Gerald Dryden, M.D.  502-852-0156
Research Coordinator:  Susie Mann, L.P.N. 502-852-1919

GASTROPARESIS

• Please check back soon.
  

HEPATITIS C

• Please check back soon.

IRRITABLE BOWEL SYNDROME

• Please check back soon.

ULCERATIVE COLITIS

• A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC).

Principal Investigator:  Gerald Dryden, M.D.  502-852-0156
Research Coordinator: Karen Sherwood, BSN 502-813-6306

• A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of Multistem (PF-05285401) in Subjects with Moderate to Severe Ulcerative Colitis.

Principal Investigator:  Gerald Dryden, M.D.  502-852-0156
Research Coordinator: Karen Sherwood, BSN 502-813-6306

OTHER MOTILITY DISORDERS

• Please check back soon.